Biopharmaceutical production is booming and consists of using cells to produce molecules of interest. To achieve this, monitoring the culture and the state of the cells is essential. Quantitative phase imaging by holography is a label-free optical method that has already demonstrated its ability to measure the concentration and viability of cultured cells. However, implementing this technique in a bioreactor faces several challenges related to the high cell density. It is therefore necessary to develop new quantitative phase imaging methods, such as differential phase contrast imaging.

The objective of the PhD is to develop this technique using a specific image sensor for which a prototype has been designed at CEA-LETI. The PhD candidate will use this new sensor and develop the reconstruction and image-processing algorithms. They will also identify the limitations of the current prototype and define the specifications for a second prototype that will be developed at CEA-LETI. Finally, they will consider the design of an inline probe to be immersed in the bioreactor.